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A histologic feature of usual interstitial pneumonia is the presence gators have noted a prognostic value of quantifying fibro-
of fibroblastic foci. As some patients with usual interstitial pneumo- blastic foci (FF) in patients with idiopathic interstitial pneu-
nia and an underlying collagen vascular disease have a better prog- monia (19, 20). Furthermore, several groups have suggested
nosis, we hypothesized that they would have fewer fibroblastic foci. differences in the alveolar microenvironment and fibroblast
Pathologists reviewed surgical lung biopsies from 108 patients with phenotype between patients with idiopathic and collagen-
usual interstitial pneumonia (nine with collagen vascular disease) vascular associated pulmonary fibrosis (21–24). We hypothe-
and assigned a score (absent 0, mild 1, moderate 2, and marked sized that patients with CVD-associated UIP would have an
3) for fibroblastic foci. Patients with idiopathic usual interstitial improved survival compared with patients with idiopathic
pneumonia had a higher median profusion of fibroblastic foci (1.75 UIP and that this improved survival would correlate with
vs. 1.0, p  0.003). Baseline characteristics were similar, although the profusion of FF.
patients with a collagen vascular disease were younger, had a
shorter duration of symptoms, and had a higher percentage of
METHODSpredicted total lung capacity. Profusion of fibroblastic foci was the
most discriminative feature for separating idiopathic from collagen Patient Recruitment and Therapy
vascular disease–associated usual interstitial pneumonia (odds ratio
This study used information from the University of Michigan Special-8.31; 95% confidence interval, 1.98, 59.42; p  0.002 for a one-
ized Center of Research in the Pathobiology of Fibrotic Lung Diseaseunit increase in fibroblastic foci score). No deaths were noted in the
database. Patients were referred for enrollment in study protocols forcollagen vascular disease–associated usual interstitial pneumonia
suspected IPF and underwent surgical lung biopsy between Octobergroup; 52 deaths occurred in the idiopathic usual interstitial pneu-
1989 and February 2000. In these patients, a suspicion of IPF was based
monia group (log rank; p 0.005). We conclude that patients with on symptoms, physiologic abnormalities, and radiographic findings (3).
collagen vascular disease–associated usual interstitial pneumonia Patients were excluded if they were found to have a disease other
have fewer fibroblastic foci and improved survival. than IPF during the enrollment evaluation. Diseases that were exclusion-
ary included pneumoconiosis, sarcoidosis, carcinoma, lymphoma, Langer-
Keywords: idiopathic pulmonary fibrosis; usual interstitial pneumonia; han’s cell histiocytosis, and lymphangioleiomyomatosis. The study was
nonspecific interstitial pneumonia; fibroblastic focus approved by the institutional review board at the University of Michigan.
Patients with pulmonary fibrosis associated with a collagen Pathologic Assessment
vascular disease (CVD) have an improved prognosis com-
Two pathologists (T.V.C. and W.D.T.) reviewed surgical lung biopsypared with patients with idiopathic pulmonary fibrosis (IPF)
slides during three review sessions between March 1999 and February(1, 2). Recently, an American Thoracic Society statement 2000. The pathologists assigned a diagnosis of UIP, nonspecific intersti-
concluded that IPF should reflect only the histologic picture tial pneumonia (NSIP), respiratory bronchiolitis interstitial lung dis-
of usual interstitial pneumonia (UIP) and exclude patients ease/desquamative interstitial pneumonia, or other (4, 11, 25). Only
with associated CVD, thus making IPF a more homogeneous patients with UIP were included in this study. The profusion of FF
for each lobe was scored semiquantitatively as 0–3 (absent 0, mild 1,group with a worse prognosis than previously described (3,
moderate 2, and marked 3) by each pathologist (Figures 1A–1C). A4). Histologic patterns other than UIP have been noted with
mean FF score for each patient was calculated by averaging the FFgreater frequency in CVD-associated interstitial lung disease
score from each lobe. A maximal FF score was recorded as the highest(5–10). As such, the improved prognosis for patients with
FF score for any lobe. The mean FF score for patients with idiopathicCVD-associated interstitial lung disease has been felt, poten-
discordant UIP versus idiopathic concordant UIP (26) was compared.tially, to relate to an increased frequency of alternative histo- Few patients with CVD had a biopsy in multiple lobes, which precluded
logic categories. the evaluation of histologic variability in this group of patients. Patho-
Recent studies have emphasized the importance of the logic scores were also evaluated (T.V.C.) using other published scoring
fibroblastic focus, a manifestation of ongoing lung injury in systems for FF (20, 27), interstitial mononuclear cell infiltrate (MC),
patients with established fibrosis (EF) (11–20). Some investi- EF, and intra-alveolar macrophages (20).
Physiologic Assessment
Physiologic assessment was performed before surgical lung biopsy and
before the initiation of therapy. Pulmonary function tests, including(Received in original form April 26, 2002; accepted in final form February 14, 2003)
spirometry, lung volumes, and diffusion capacity for carbon monoxide,
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prospectively and independently scored all lobes on HRCT for ground
glass opacity (CT-alv) and interstitial opacity (CT-fib) on a scale of 0–5
as described previously (28, 29). The radiologists were also asked to
give an HRCT diagnosis of UIP, indeterminate (equal probability of
UIP and NSIP), or NSIP (30). The radiologists were unaware of the
histologic diagnosis at the time of interpretation.
Statistical Analysis
Categorical data were compared between patients with idiopathic UIP
and CVD-associated UIP using Fisher’s exact tests (31), and continuous
data were compared using Wilcoxon rank-sum tests (32). Nonparamet-
ric tests were used because of the small number of patients in the CVD-
associated UIP group. Because the Wilcoxon rank-sum test is designed
to detect median differences, continuous baseline characteristics are
summarized using median values with ranges. The overall survival expe-
rience for each group of patients was estimated using Kaplan–Meier
curves (33). The lack of deaths in the CVD-associated UIP group
precluded the use of Cox regression analysis to evaluate the potential
impact of baseline factors on survival in this group (34). To evaluate
whether baseline differences between patients with idiopathic UIP and
CVD-associated UIP accounted for differences in survival, stratified
log-rank analyses were performed across variables that were different
at baseline. Tertiles were used to stratify on age and percentage pre-
dicted total lung capacity (TLC); the median time before biopsy was
used as a cutoff for the strata of onset of symptoms. Stuart’s Tau-c
statistics were used to compare the different scoring systems of FF. In
addition, logistic regression was used to examine relationships between
the presence/absence of CVD and other variables (35).
RESULTS
Patient Population
During the study period, 99 patients with idiopathic UIP and 9
with CVD-associated UIP were identified. Five additional pa-
tients with histologic NSIP in combination with CVD that are
not included in this research were evaluated during the same
time period. The associated diagnoses in the CVD-associated
UIP patients were rheumatoid arthritis (n  4), polymyositis
(n  2), mixed connective tissue disease (n  1), systemic lupus
erythematosis (n  1), and systemic sclerosis (n  1).
Baseline Characteristics
Patients with idiopathic UIP had a higher profusion of FF com-
pared with patients with UIP associated with CVD (Figure 2
and Table 1) when either the mean FF profusion (p  0.003)
or maximal FF profusion was examined (p  0.0004). The level
of agreement for FF scores between pathologists was excellent,
with  statistics ranging from 0.81–1.0 within each lobe. Baseline
demographic, physiologic, and HRCT characteristics were simi-
lar, although patients with CVD-associated UIP were younger,
had a shorter duration of symptoms, and had a higher percentage
of predicted TLC (Table 1). In patients with CVD-associated
UIP, the HRCT diagnosis was compatible with NSIP in 67% of
the patients compared with UIP in 33%. There were no other
unique/discriminatory findings noted on the HRCT scans from
the patients with CVD-associated UIP. Patients with idiopathic
discordant UIP had a lower median profusion of FF compared
with patients with idiopathic concordant UIP (1.3 [0.3, 2.5] versus
2 [0.5, 3.0], p  0.0005, Wilcoxon rank sum test). A lack of
multiple lobe biopsies for patients with CVD-associated UIP
precluded a similar analysis in these patients.
Associations Between Scoring Systems
Figure 1. (A–C) Representative photomicrographs from histopathologic
Associations between the three pathologic scoring systems forsections of surgical lung biopsy specimens from patients with a FF score
FF were positive for each two-way comparison. A positive rela-of 1 (mild, A ), 2 (moderate, B ), and 3 (marked, C ).
tionship was found in the comparison of the Brompton FF
method (20) and our method (0.56, 95% confidence interval
[CI], 0.46–0.67), the Denver FF method (27) and our method
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(0.55, 95% CI, 0.43–0.66), and the Brompton FF and Denver
FF methods (0.48, 95% CI, 0.36–0.60).
Association of Baseline Characteristics With CVD
The mean FF and max FF were the most discriminative baseline
features for separating idiopathic UIP from CVD-associated
UIP. In univariate analysis (Table 2), the odds ratio of having
idiopathic UIP compared with UIP associated with a CVD was
8.31 for a unit increase in mean FF score (95% CI, 1.98, 59.42;
p  0.002) and 16.99 higher for a unit increase in max FF score
(95% CI, 3.28, 316; p  0.0001). The results were similar for the
Brompton FF method (odds ratio 3.23; 95% CI 1.17, 15.4; p 
0.02) and the Denver FF method (odds ratio 1.87; 95% CI, 0.89,
5.03; p  0.10), although these associations were less extreme
in magnitude and statistical significance. Mean FF remained
significant or marginally significant when added to a model con-
taining age at biopsy (likelihood ratio p value 0.005) or onset of
symptoms (likelihood ratio p value  0.065) or TLC percentage
predicted (likelihood ratio p value  0.003). Models, including
other pathologic features (MC, EF, intra-alveolar macrophages),
FEV1, FVC, diffusion capacity for carbon monoxide, and HRCT
Figure 2. Dot plots showing the mean FF score for each lobe evaluated interstitial or alveolar values, were not statistically significant.
from patients with idiopathic UIP or CVD- associated UIP. The median
Survivalprofusion of FF was greater in the lobes from patients with idiopathic
UIP compared with those with CVD-associated UIP (median [range] 2 Patients with CVD-associated UIP had an improved survival com-
[0, 3] versus 1 [0, 2]; p  0.003; Wilcoxon rank sum test). pared with patients with idiopathic UIP (Figure 3). No deaths
were noted in the CVD-associated UIP group during a median
follow-up of 3.5 years (95% CI 2.5, ∞). This survival advantage
was in marked contrast to the 52 deaths (53%) in the idiopathic
TABLE 1. BASELINE CHARACTERISTICS FOR PATIENTS WITH IDIOPATHIC USUAL INTERSTITIAL
PNEUMONIA AND PATIENTS WITH COLLAGEN VASCULAR DISEASE–ASSOCIATED USUAL
INTERSTITIAL PNEUMONIA
Idiopathic UIP CVD UIP p Value
Characteristic Median (Range) Median (Range) Fisher’s Exact
Sex, male/female 46/53 6/3 0.31
Age at biopsy, yr 62 (26, 78) 54 (34, 71) 0.02
Symptom onset, yr 2.0 (0.1, 20.0) 0.5 (0.3, 2.0) 0.01
Packs per day  years (pack-years) 10 (0, 100) 0 (0, 50) 0.30
Fibroblastic foci
Mean of lobes 1.75 (0.3, 3.0) 1.0 (0.7, 2) 0.003
Max in any lobe 2 (1, 3) 1 (1, 2) 0.0004
BFF 2.3 (1, 6) 1.3 (1, 3) 0.02
DFF 2.1 (0, 7) 1.3 (0,3) 0.17
Other pathologic features
Established fibrosis (20) 3.7 (1.3, 5) 2.7 (2, 4) 0.10
Mononuclear cell infiltrate (20) 2.5 (0.5, 6) 2.8 (2, 4) 0.12
Intra-alveolar macrophages (20) 2.3 (1, 5.3) 1.5 (1, 5.3) 0.35
Spirometry
FVC, L 2.18 (0.81, 5.57) 2.35 (1.46, 5.05) 0.39
FVC, percentage predicted 61 (23, 114) 68 (39, 109) 0.20
FEV1, L 1.76 (0.71, 4.37) 2.01 (1.18, 3.09) 0.51
FEV1, % predicted 68 (26, 131) 73 (41, 94) 0.78
Lung volume
TLC, L 3.65 (2.12, 7.80) 4.52 (3.32, 9.12) 0.08
TLC, % predicted 72 (42, 121) 92 (69, 135) 0.04
Gas exchange
DLCO, ml/min/mm Hg 11.3 (3.42, 25.9) 13.29 (6.97, 19.33) 0.11
DLCO, % predicted 45 (13, 89) 61 (29,66) 0.14
HRCT
Alveolar (CT-Alv) 1.65 (0.5, 4.2) 1.75 (0.8, 3.2) 1.0
Interstitial (CT-Fib) 1.9 (0, 3.6) 1.65 (0.7, 3.6) 0.68
Definition of abbreviations: BFF  Brompton fibroblastic foci scoring method (20); CVD  collagen vascular disease; DFF 
Denver fibroblastic foci scoring method (27); DLCO  diffusing capacity for carbon monoxide; HRCT  high-resolution computed
tomography; TLC  total lung capacity; UIP  usual interstitial pneumonia.
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TABLE 3. UNIVARIATE COX PROPORTIONAL HAZARDTABLE 2. UNIVARIATE LOGISTIC REGRESSION PREDICTING
THE PRESENCE OF IDIOPATHIC USUAL INTERSTITIAL MODELS EXAMINING THE EFFECT OF PATHOLOGIC
FEATURES ON SURVIVALPNEUMONIA COMPARED WITH COLLAGEN VASCULAR
DISEASE–ASSOCIATED USUAL INTERSTITIAL PNEUMONIA
HR
Predictor (95% CI) p ValuePredictor Odds Ratio 95% CI* p Value*
Age at biopsy, yr 1.06 (1.00, 1.12) 0.048 All patients
Mean fibroblastic foci* 1.62 (1.08, 2.44) 0.02Mean fibroblastic foci score of lobes 8.31 (1.98, 59.42) 0.002
Max fibroblastic foci score of lobes 16.99 (3.28, 316)  0.0001 Max fibroblastic foci* 1.61 (1.05, 2.47) 0.03
DFF 1.21 (0.97, 1.51) 0.09Symptom onset, years 2.9 (1.3, 11.9) 0.004
TLC, % predicted 0.95 (0.90, 0.99) 0.011 BFF 1.31 (1.04, 1.66) 0.02
Mononuclear cell infiltrate† 0.90 (0.63, 1.28) 0.06DFF 1.87 (0.89, 5.03) 0.10
BFF 3.23 (1.17, 15.4) 0.02 Established fibrosis† 1.54 (1.04, 2.28) 0.03
Intra-alveolar macrophages† 1.01 (0.77, 1.33) 0.93Mononuclear cell infiltrate† 0.53 (0.21, 1.20) 0.12
Established fibrosis† 2.03 (0.83, 5.6) 0.12 Only idiopathic UIP patients
Mean fibroblastic foci* 1.33 (0.86, 2.05) 0.20Intra-alveolar macrophages† 1.18 (0.56, 3.01) 0.68
Max fibroblastic foci* 1.23 (0.78, 1.94) 0.38
Definition of abbreviations: BFF Brompton fibroblastic foci scoring system (20); DFF 1.11 (0.87, 1.41) 0.39
CI  confidence interval; DFF  Denver fibroblastic foci scoring system (27); TLC  BFF 1.21 (0.95, 1.54) 0.13
total lung capacity. Mononuclear cell infiltrate† 0.97 (0.69, 1.37) 0.87
* Confidence intervals and p values based on likelihood ratio test. Established fibrosis† 1.3 (0.88, 1.93) 0.19
† As described by Nicholson and colleagues (20). Intra-alveolar macrophages† 1.02 (0.76, 1.35) 0.91
Definition of abbreviations: BFF brompton fibroblastic foci scoring system (20);
CI  confidence interval; DFF  Denver fibroblastic foci scoring system (27); HR 
hazard ratio; UIP  usual interstitial pneumonia.UIP group (log rank p  0.005), where the median survival was
* Fibroblastic foci score as described in METHODS.
2.7 years (95% CI, 2.4, 5.1). To account for baseline differences † As described by Nicholson and colleagues (20).
in age, percentage predicted TLC and onset of symptoms strati-
fied log-rank analyses were used to compare survival between the
two disease groups. Improved survival for patients with CVD-
associated UIP was confirmed in all stratified analyses, with p profusion of FF between patients with idiopathic UIP and CVD-
values of 0.006, 0.05, and 0.04 for age, percentage predicted TLC, associated UIP. In fact, the profusion of FF was the most discrim-
and onset of symptoms, respectively. When all patients were inative baseline feature between idiopathic and CVD-associated
analyzed as a group in univariate models, the profusion of FF UIP, as identified by logistic regression. The magnitude of this
and the amount of EF were associated with survival (Table 3). difference persisted even when accounting for demographic,
This may be a consequence of FF acting as a surrogate for the physiologic, and radiographic features. This is contrast to the
presence/absence of CVD; when only idiopathic UIP patients results of others (24) and may reflect differences in the patient
were evaluated, no pathologic feature was associated with sur- population, histopathologic classification, or the scoring systems
vival. The lack of deaths in the CVD-associated UIP group used for profusion of FF. Several patients previously classified
precluded the analysis of this group independently. as UIP have been reclassified as NSIP after another review using
the latest histopathologic criteria (4, 11, 25). Recent data suggests
DISCUSSION that a histologic picture of NSIP is frequently identified in
patients with CVD (5–10). In addition, NSIP appears to beIn this study, we identified a lower profusion of FF in patients
associated with an improved prognosis (7, 26, 36–40). To ensurewith CVD-associated UIP compared with patients with idio-
accurate histopathologic classification, the histologic samplespathic UIP. We also confirm an improved survival for patients
from each or our patients were felt to represent the histologicwith CVD-associated UIP.
pattern of UIP when reviewed independently by two expertA novel feature of this study is the marked difference in the
pulmonary pathologists (W.T. and T.C.) using the latest diagnos-
tic criteria (4, 11, 25).
The differential profusion of FF despite a similar amount of
fibrosis on HRCT suggests that the underlying pathogenesis of
fibrosis in these diseases may be distinctly different. Idiopathic
UIP is a disease that is localized to the lung parenchyma. This
observation has led to the suggestion that the etiologic agent in
UIP might represent an unidentified inhaled antigen. CVDs are
systemic illnesses that are characterized by the involvement of
multiple organ systems suggesting that the etiologic agent might
represent a circulating “autoantigen.” Thus, one might speculate
that the formation of FF in UIP is promoted by initial injury to
the alveolar epithelium versus the vascular endothelium. Indeed,
UIP has been recently characterized as an “epithelial-fibroblastic
disease” in which inflammation plays only a minor role (41).
Improved survival was noted for patients with CVD-associ-
ated UIP compared with patients with idiopathic UIP. The im-
proved survival for patients with CVD-associated UIP may be
related to either the decreased profusion, or perhaps differen-
tial function, of the FF. Morphologic studies have suggested
fibroblasts play an active role in the remodeling of the lung inFigure 3. Kaplan-Meier survival curves in patients with CVD UIP (dashed
line) and idiopathic UIP (solid line; log-rank test, p  0.005). pulmonary fibrosis (13, 16), and increasing data suggest that
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the fibroblastic focus represents a site of active, ongoing injury A limitation of this study is the small number of patients with
adding to the EF (11, 13–17, 38, 41). Several authors have sug- CVD-associated UIP. This may be due to more patients with
gested that differences in fibroblast function and cytokine pro- CVD having other histologic patterns such as NSIP (5–10) or a
files exist in patients with CVD (22, 23, 42–44). Although our decreased tendency to perform a surgical lung biopsy in these
study did not directly address the phenotype of the fibroblasts patients. The overall similarity of physiologic and radiographic
contained in FF, it clearly demonstrates that increased profusion characteristics for the patients in this study argues against a
of FF in idiopathic UIP is associated with a poorer prognosis significant selection bias in selecting patients for biopsy. The
when compared with CVD-associated UIP. striking results, even with a small sample size, also argue that
Several scoring systems for FF have been described (19, 20). genuine differences exist for patients with a histologic pattern
We demonstrate a moderate correlation between these methods. of UIP with, versus without, an associated CVD. Future studies
Unlike other reports (19, 20), we did not find the profusion of are required to clarify the role of FF in the pathogenesis of UIP.
FF, by any method, to be a significant predictor of survival for In summary, we have shown that patients with CVD-associ-
patients with idiopathic UIP. This may reflect subtle differences ated UIP have a markedly improved survival compared with
in inclusion criteria. A differential application of the scoring patients with idiopathic UIP. Furthermore, patients with CVD-
systems is also possible but seems less likely given that the same associated UIP have a decreased profusion of FF compared with
pathologist (T.V.C.) participated in all studies. Further studies patients with idiopathic UIP.
are needed to define the importance of and optimal way to score
the profusion of FF. References
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